Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio: 2009-2025
Historic Asset Utilization Ratio for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to 0.42.
- Teva Pharmaceutical Industries' Asset Utilization Ratio rose 3.91% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year increase of 3.91%. This contributed to the annual value of 0.40 for FY2024, which is 10.31% up from last year.
- According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Asset Utilization Ratio is 0.42, which was down 0.93% from 0.42 recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Asset Utilization Ratio ranged from a high of 0.43 in Q1 2025 and a low of 0.33 during Q1 2021.
- In the last 3 years, Teva Pharmaceutical Industries' Asset Utilization Ratio had a median value of 0.39 in 2024 and averaged 0.39.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Asset Utilization Ratio declined by 0.16% in 2022 and then climbed by 15.19% in 2025.
- Over the past 5 years, Teva Pharmaceutical Industries' Asset Utilization Ratio (Quarterly) stood at 0.33 in 2021, then grew by 1.72% to 0.34 in 2022, then climbed by 9.50% to 0.37 in 2023, then grew by 10.19% to 0.41 in 2024, then rose by 3.91% to 0.42 in 2025.
- Its Asset Utilization Ratio stands at 0.42 for Q3 2025, versus 0.42 for Q2 2025 and 0.43 for Q1 2025.